CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in

miR-34a exerts as a key regulator in the dedifferentiation of

Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges

PDF) CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in

Activation of miR-34a impairs autophagic flux and promotes

Mir-34: A New Weapon Against Cancer? - ScienceDirect

Mitomycin C from Streptomyces caespitosus from MilliporeSigma

Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling. - Abstract - Europe PMC

CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in

miR-34a targets the IRE1α branch of the UPR. (A,B,C) Schematic

miR-34a exerts as a key regulator in the dedifferentiation of

SPARCLE, a p53-induced lncRNA, controls apoptosis after genotoxic

Hypoxia-induced IRE1A is repressed by miR-34a. (a) Western blot

IJMS, Free Full-Text